首页|基于Notch与Wnt/β-catenin通路探讨黄芪甲苷对人成纤维细胞间质转化的作用

基于Notch与Wnt/β-catenin通路探讨黄芪甲苷对人成纤维细胞间质转化的作用

扫码查看
目的 基于Notch与Wnt/β-catenin通路,探讨黄芪甲苷(astragaloside Ⅳ,AS-Ⅳ)对类风湿关节炎相关间质性肺病(rheumatoid arthritis associated interstitial lung disease,RA-ILD)体外模型的作用机制。方法 用 Luminex 检测法对RA-ILD模型鼠支气管肺泡灌洗液中细胞因子进行检测,筛选出关键细胞因子;共培养人髓系白血病单核细胞(human myeloid leukemia mononuclear cells,THP-1)与正常人肺成纤维细胞(normal human lung fibroblast,NHLF)两种细胞系,加入关键细胞因子模拟RA-ILD体外模型,给予不同干预措施。通过RT-PCR、Western blot、COIP、EdU、ELISA以及双荧光素酶报告基因活性检测方法观察Snail、ZEB-1及E-Cadherin的启动子活性及mRNA表达、Notch通路中的关键蛋白表达、β-catenin的核转位水平、NHLF细胞增殖速率、Col Ⅰ、Col Ⅲ及Fibronectin的分泌水平以及β-catenin与NICD、β-catenin与LEF、NICD与CSL的相互作用。结果 使用细胞因子处理NHLF细胞后,Snail、ZEB-1的启动子活性及mRNA表达明显增高,Notch通路中的关键蛋白表达水平显著上调,β-catenin的核转位明显增加,EdU阳性细胞明显增加;细胞上清中Col Ⅰ、Col Ⅲ及Fibronectin分泌水平显著上调,同时β-catenin与NICD、β-catenin与LEF、NICD与CSL的蛋白结合明显增加;使用Notch抑制剂DAPT和Jagged1 shRNA时结果与上述结论相反;AS-Ⅳ能够通过抑制Jagged1进而下调Notch及β-catenin信号通路的过度活化,抑制β-catenin与NICD、β-catenin与LEF、NICD与CSL的 蛋白结合,能够剂量依赖性地抑制Snail及ZEB-1并上调E-Cadherin的启动子活性、mRNA和蛋白表达水平,抑制NHLF细胞的过度增殖及Col Ⅰ、Col Ⅲ、Fibronectin的分泌。结论 AS-Ⅳ可能通过抑制Notch和Wnt/β-catenin信号通路,抑制NHLF细胞增殖,减少ECM过度沉积,从而减缓RA-ILD肺间质纤维化进展。
Study on Effect of Astragaloside Ⅳ on Mesenchymal Transition of Human Fibroblasts Based on Notch and Wnt/β-catenin Pathway
Objective To investigate the mechanism of astragaloside Ⅳ(AS-Ⅳ)in an in vitro model of rheumatoid arthritis-associated interstitial lung disease(RA-ILD)based on Notch and Wnt/β-catenin pathways.Methods Inflammatory factors were detected in the bronchoalveolar lavage fluid of RA-ILD model rats by Luminex assay to screen out key inflammatory factors.Two cell lines,THP-1 and NHLF,were co-cultured,and inflammatory factors were added to simulate RA-ILD in vitro model with different interventions.The promoter activity and mRNA expressions of Snail,ZEB-1 and E-Cadherin,expres-sions of key proteins in Notch pathway,nuclear translocation level of β-catenin and the proliferation of NHLF cells,the secre-tion levels of Col Ⅰ,Col Ⅲ and Fibronectin,and the interaction of β-catenin with NICD,β-catenin with LEF,and NICD with CSL were observed by RT-PCR,Western blot,COIP,EdU,ELISA and dual luciferase reporter gene activity assays.Result-s After NHLF cells were treated with inflammatory factors,the promoter activity and mRNA expressions of Snail and ZEB-1 were significantly increased,the expression levels of key proteins in the Notch pathway were significantly up-regulated,the nuclear translocation of β-catenin was significantly increased,and EdU-positive cells were significantly increased.The secretion levels of Col Ⅰ,Col Ⅲ and Fibronectin in cell supernatants were significantly up-regulated,while the protein binding of β-catenin with NICD,β-catenin with LEF and NICD with CSL was significantly increased.The results were the opposite when using the Notch inhibitors DAPT and Jagged1 shRNA.AS-Ⅳ was able to down-regulate the overactivation of Notch and β-catenin sig-naling pathways by inhibiting Jagged1 and thus AS-Ⅳ was able to inhibit the excessive activation of Notch and β-catenin sig-naling pathways,inhibit the protein binding of β-catenin with NICD,β-catenin with LEF and NICD with CSL,dose-depend-ently inhibit Snail and ZEB-1 and up-regulate the promoter activity,mRNA and protein expression levels of E-Cadherin,in-hibit the excessive proliferation of NHLF cells and the secretion of Col Ⅰ,Col Ⅲ and Fibronectin.Conclusion AS-Ⅳ may inhibit NHLF cell proliferation and reduce excessive ECM deposition by suppressing Notch and Wnt/β-catenin signaling pathways,thereby slowing the progression of RA-ILD interstitial lung fibrosis.

rheumatoid arthritisinterstitial lung diseasefibroblastastragaloside ⅣNotch signaling pathwayWnt/β-cate-nin signaling pathway

龚晓红、李桓、陆超群、武上雯、邢清桦、李松伟

展开 >

河南中医药大学,河南郑州 450000

河南中医药大学第一附属医院,河南郑州 450000

河南省中医院,河南中医药大学第二附属医院,河南郑州 450000

类风湿关节炎 间质性肺病 成纤维细胞 黄芪甲苷 Notch信号通路 Wnt/β-catenin信号通路

国家自然科学基金项目国家自然科学基金项目河南省自然科学基金项目河南省科技攻关项目河南省科技计划联合基金项目河南省中医药科学研究专项河南省中医药科学研究专项河南省中医药拔尖人才项目河南省中医药临床研究基地专项河南中医药大学科研创新项目

8157395281874465222300420228222102310392222230142008920-21ZYZD162022ZY10152022ZYBJ102022ZY10152021KYCX003

2024

中华中医药学刊
中华中医药学会 ,辽宁中医药大学

中华中医药学刊

CSTPCD北大核心
影响因子:1.007
ISSN:1673-7717
年,卷(期):2024.42(4)
  • 42